Prescription drug cost-sharing is a barrier to medication adherence, particularly for low-income and minority populations. In this systematic review, we examined the impact of prescription drug cost-sharing and policies to reduce cost-sharing on racial/ethnic and income disparities in medication utilization. We screened 2,145 titles and abstracts and identified 19 peer-reviewed papers that examined the interaction between cost-sharing and racial/ethnic and income disparities in medication adherence or utilization. We found weak but inconsistent evidence that lower cost-sharing is associated with reduced disparities in adherence and utilization, but studies consistently found that significant disparities remained even after adjusting for differences in cost-sharing across individuals. Study designs varied in their ability to measure the causal effect of policy or cost-sharing changes on disparities, and a wide range of policies were examined across studies. Further research is needed to identify the types of policies that are best suited to reduce disparities in medication adherence.
AdamsA. S.MaddenJ. M.ZhangF.SoumeraiS. B.GildenD.GriggsJ.. . .Ross-DegnanD. (2014). Changes in use of lipid lowering medications among black and white dual enrollees with diabetes transitioning from Medicaid to Medicare Part D drug coverage. Medical Care, 52(8), 695–703.
2.
AdamsA. S.SoumeraiS. B.ZhangF.GildenD.BurnsM.HuskampH. A.. . .MaddenJ. M. (2015). Effects of eliminating drug caps on racial differences in antidepressant use among dual enrollees with diabetes and depression. Clinical Therapeutics, 37(3), 597–609. https://doi.org/10.1016/j.clinthera.2014.12.011
3.
BaileyJ. E.WanJ. Y.TangJ.GhaniM. A.CushmanW. C. (2010). Antihypertensive medication adherence, ambulatory visits, and risk of stroke and death. Journal of General Internal Medicine, 25, 495–503.
4.
BakkL. (2015). Racial/ethnic differences in cost-related nonadherence and Medicare Part D: A longitudinal comparison. Journal of Health Care for the Poor and Underserved, 26(4), 1132–1148. https://doi.org/10.1353/hpu.2015.0113
5.
BiggersA.ShiY.CharlsonJ.SmithE. C.SmallwoodA. J.NattingerA. B.. . .NeunerJ. M. (2016). Medicare D subsidies and racial disparities in persistence and adherence with hormonal therapy. Journal of Clinical Oncology, 34(36), 4398–4404. https://doi.org/10.1200/jco.2016.67.3350
6.
CamachoF. T.TanX.AlcaláH. E.ShahS.AndersonR. T.BalkrishnanR. (2017). Impact of patient race and geographical factors on initiation and adherence to adjuvant endocrine therapy in medicare breast cancer survivors. Medicine (Baltimore), 96(24), Article e7147. https://doi.org/10.1097/md.0000000000007147
7.
CarrollW. A.MillerG. E.HillS. C. (2020). Out-of-pocket spending for retail prescribed drugs by age and type of prescription drug coverage 2009 to 2018. Agency for Healthcare Research and Quality.
8.
ChernewM.GibsonT. B.Yu-IsenbergK.SokolM. C.RosenA. B.FendrickA. M. (2008). Effects of increased patient cost sharing on socioeconomic disparities in health care. Journal of General Internal Medicine, 23(8), 1131–1136. https://doi.org/10.1007/s11606-008-0614-0
9.
ChoudhryN. K.AvornJ.GlynnR. J.AntmanE. M.SchneeweissS.ToscanoM.. . .LeeJ. L. (2011). Full coverage for preventive medications after myocardial infarction. New England Journal of Medicine, 365(22), 2088–2097.
10.
DusetzinaS. B.HuskampH. A.RothmanR. L.PinheiroL. C.RobertsA. W.ShahN. D.. . .KeatingN. L. (2022). Many Medicare beneficiaries do not fill high-price specialty drug prescriptions. Health Affairs, 41(4), 487–496. https://doi.org/10.1377/hlthaff.2021.01742
11.
FariasA. J.DuX. L. (2017). Association between out-of-pocket costs, race/ethnicity, and adjuvant endocrine therapy adherence among Medicare patients with breast cancer. Journal of Clinical Oncology, 35(1), 86–95. https://doi.org/10.1200/jco.2016.68.2807
12.
FungV.PriceM.McDowellA.NierenbergA. A.HsuJ.NewhouseJ. P.CookB. L. (2023). Coverage parity and racial and ethnic disparities in mental health and substance use care among Medicare beneficiaries. Health Affairs, 42(1), 83–93.
HertzR. P.UngerA. N.CornellJ. A.SaundersE. (2005). Racial disparities in hypertension prevalence, awareness, and management. Archives of Internal Medicine, 165(18), 2098–2104.
15.
HolmesH. M.LuoR.HanlonJ. T.EltingL. S.Suarez-AlmazorM.GoodwinJ. S. (2012). Ethnic disparities in adherence to antihypertensive medications of Medicare Part D beneficiaries. Journal of the American Geriatrics Society, 60(7), 1298–1303. https://doi.org/10.1111/j.1532-5415.2012.04037.x
16.
HusseinM.WatersT. M.ChangC. F.BaileyJ. E.BrownL. M.SolomonD. K. (2016). Impact of Medicare Part D on racial disparities in adherence to cardiovascular medications among the elderly. Medical Care Research and Review, 73(4), 410–436. https://doi.org/10.1177/1077558715615297
17.
KaestnerR.KhanN. (2012). Medicare Part D and its effect on the use of prescription drugs and use of other health care services of the elderly: Medicare Part D and its effect. Journal of Policy Analysis and Management, 31(2), 253–279. https://doi.org/10.1002/pam.21625
18.
KennedyJ. J.MaciejewskiM.LiuD.BlodgettE. (2011). Cost-related nonadherence in the Medicare program: The impact of Part D. Medical Care, 522–526.
19.
KesselheimA. S.HwangT. J.AvornJ. (2021). Paying for prescription drugs in the new administration. JAMA, 325(9), 819–820. doi:10.1001/jama.2021.0009
20.
KirkJ. K.D’AgostinoR. B.Jr.BellR. A.PassmoreL. V.BondsD. E.KarterA. J.NarayanK. V. (2006). Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: A meta-analysis. Diabetes Care, 29(9), 2130–2136.
21.
KogutS. J. (2020). Racial disparities in medication use: Imperatives for managed care pharmacy. Journal of Managed Care & Specialty Pharmacy, 26(11), 1468–1474. https://doi.org/10.18553/jmcp.2020.26.11.1468
22.
LeeJ. L.MaciejewskiM.RajuS.ShrankW. H.ChoudhryN. K. (2013). Value-based insurance design: Quality improvement but no cost savings. Health Affairs (Millwood), 32(7), 1251–1257. https://doi.org/10.1377/hlthaff.2012.0902
23.
LeweyJ.ShrankW. H.AvornJ.LiuJ.ChoudhryN. K. (2015). Medication adherence and healthcare disparities: Impact of statin co-payment reduction. American Journal of Managed Care, 21(10), 696–704.
24.
LexchinJ.GrootendorstP. (2004). Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: A systematic review of the evidence. International Journal of Health Services, 34(1), 101–122. https://doi.org/10.2190/4m3e-l0yf-w1td-ekg0
25.
MoherD.LiberatiA.TetzlaffJ.AltmanD. G. & PRISMA Group* t. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Annals of Internal Medicine, 151(4), 264–269.
26.
ParkY. J.MartinE. G. (2017). Medicare Part D’s effects on drug utilization and out-of-pocket costs: A systematic review. Health Services Research, 52(5), 1685–1728. https://doi.org/10.1111/1475-6773.12534
27.
PolinskiJ. M.KilabukE.SchneeweissS.BrennanT.ShrankW. H. (2010). Changes in drug use and out-of-pocket costs associated with Medicare Part D implementation: A systematic review. Journal of the American Geriatrics Society, 58(9), 1764–1779. https://doi.org/10.1111/j.1532-5415.2010.03025.x
28.
RobertsE. T.KwonY.HamesA. G.McWilliamsJ. M.AyanianJ. Z.TipirneniR. (2023). Racial and ethnic disparities in health care use and access associated with loss of Medicaid supplemental insurance eligibility above the federal poverty level. JAMA Internal Medicine.
29.
TamblynR.LapriseR.HanleyJ. A.AbrahamowiczM.ScottS.MayoN.. . .PerreaultR. (2001). Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA, 285(4), 421–429.
30.
TsangC. C. S.BrowningJ.TodorL.DoughertyS.HohmeierK. C.LiM. S.. . .WangJ. (2021). Factors associated with medication nonadherence among Medicare low-income subsidy beneficiaries with diabetes, hypertension, and/or heart failure. Journal of Managed Care & Specialty Pharmacy, 27(8), 971–981.
31.
VermeireE.HearnshawH.Van RoyenP.DenekensJ. (2001). Patient adherence to treatment: Three decades of research. A comprehensive review. Journal of Clinical Pharmacy and Therapeutics, 26(5), 331–342.
32.
XieZ.St ClairP.GoldmanD. P.JoyceG. (2019). Racial and ethnic disparities in medication adherence among privately insured patients in the United States. PLOS ONE, 14(2), Article e0212117. https://doi.org/10.1371/journal.pone.0212117
33.
ZhangY.BaikS. H. (2014). Race/ethnicity, disability, and medication adherence among Medicare beneficiaries with heart failure. Journal of General Internal Medicine, 29(4), 602–607. https://doi.org/10.1007/s11606-013-2692-x
34.
ZhangY.BaikS. H.ChangC. C.KaplanC. M.LaveJ. R. (2012). Disability, race/ethnicity, and medication adherence among Medicare myocardial infarction survivors. American Heart Journal, 164(3), 425–433e424. https://doi.org/10.1016/j.ahj.2012.05.021
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
